Work led by MPWRM Resource Center Principal Investigator, Dr. David Mooney, and collaborators were featured in: CAR-T cell cancer immunotherapy gets personal. Learn more about this new work on the Wyss Institute website.  “We show that CAR-T cell products made from T cells derived from cancer patients are generally less functional than CAR-T cells products derived from healthy individuals,” said Founding Wyss Core Faculty member  and MPWRM PI Dr. David Mooney.